WASHINGTON (AP) — Three people with a muscle-destroying disease destined to worsen got a little stronger – able to stand and walk more easily – when an implanted device zapped their spinal cord.

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

WASHINGTON — Three people with a muscle-destroying disease destined to worsen got a little stronger – able to stand and walk more easily – when an implanted device zapped their spinal cord.

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Spinal cord stimulators have become a cornerstone for severe back ... Leading players in the neurostimulation devices market include Medtronic, Boston Scientific, Abbott, LivaNova, NEVRO, and ...

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

Introduction to Wearable Artificial OrgansThe field of wearable artificial organs (WAOs) is a game-changer in modern medicine, offering innovative solutions that replicate the functions of human ...

Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency ...

The PoC grants, which are worth €150,000 each, intend to help the researchers “bridge the gap” between their scientific ... specific stimulation implant for spinal cord injuries.